Validation and reproducibility assessment of tigecycline MIC determinations by Etest
- PMID: 17522277
- PMCID: PMC1951261
- DOI: 10.1128/JCM.00089-07
Validation and reproducibility assessment of tigecycline MIC determinations by Etest
Abstract
A multicenter study was conducted to validate Etest tigecycline compared to the Clinical Laboratory Standards Institute reference broth microdilution and agar dilution methodologies. A large collection of gram-negative (n = 266) and gram-positive (n = 162) aerobic bacteria, a collection of anaerobes (n = 385), and selected collections of nonpneumococcal streptococci (n = 369), Streptococcus pneumoniae (n = 372), and Haemophilus influenzae (n = 372) were tested. Strains with reduced susceptibility to tigecycline were used with all test methods. The Etest showed excellent inter- and intralaboratory reproducibility for all organism groups tested regardless of the test methodology. The essential agreement values with the reference method (+/-1 dilution) were >99% for the collection of gram-negative and gram-positive aerobes; >98% for the S. pneumoniae, H. influenzae, and anaerobe collections; and 100% for the group of nonpneumococcal streptococci. These results validate the performance accuracy and utility of Etest tigecycline and verify the reproducibility of this convenient predefined gradient methodology for tigecycline susceptibility determination.
Figures



Similar articles
-
Determination of disc breakpoints and evaluation of Etests for tigecycline susceptibility testing by the BSAC method.J Antimicrob Chemother. 2007 Oct;60(4):770-4. doi: 10.1093/jac/dkm297. Epub 2007 Aug 18. J Antimicrob Chemother. 2007. PMID: 17704517
-
Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents.Diagn Microbiol Infect Dis. 2005 Jul;52(3):181-6. doi: 10.1016/j.diagmicrobio.2005.05.005. Diagn Microbiol Infect Dis. 2005. PMID: 16105562
-
Susceptibility to tigecycline of isolates from samples collected in hospitalized patients with secondary peritonitis undergoing surgery.Diagn Microbiol Infect Dis. 2010 Mar;66(3):308-13. doi: 10.1016/j.diagmicrobio.2009.10.018. Diagn Microbiol Infect Dis. 2010. PMID: 20022193
-
[Tigecycline, the first of a new class of antibiotics: the glycylcyclines].Rev Esp Quimioter. 2007 Mar;20(1):19-35. Rev Esp Quimioter. 2007. PMID: 17530033 Review. Spanish. No abstract available.
-
Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations.Diagn Microbiol Infect Dis. 2009 Jun;64(2):202-12. doi: 10.1016/j.diagmicrobio.2009.01.017. Epub 2009 Mar 25. Diagn Microbiol Infect Dis. 2009. PMID: 19321284 Review.
Cited by
-
Clinical and microbiological characteristics of tigecycline non-susceptible Klebsiella pneumoniae bacteremia in Taiwan.BMC Infect Dis. 2014 Jan 1;14:1. doi: 10.1186/1471-2334-14-1. BMC Infect Dis. 2014. PMID: 24380631 Free PMC article.
-
Comparison of Etest, disk diffusion, and broth macrodilution for in vitro susceptibility testing of Rhodococcus equi.J Clin Microbiol. 2015 Jan;53(1):314-8. doi: 10.1128/JCM.02673-14. Epub 2014 Nov 5. J Clin Microbiol. 2015. PMID: 25378571 Free PMC article.
-
First comprehensive evaluation of the M.I.C. evaluator device compared to Etest and CLSI reference dilution methods for antimicrobial susceptibility testing of clinical strains of anaerobes and other fastidious bacterial species.J Clin Microbiol. 2012 Apr;50(4):1153-7. doi: 10.1128/JCM.05397-11. Epub 2012 Jan 11. J Clin Microbiol. 2012. PMID: 22238439 Free PMC article.
-
Comparative evaluation of tigecycline susceptibility testing methods for expanded-spectrum cephalosporin- and carbapenem-resistant gram-negative pathogens.J Clin Microbiol. 2012 Nov;50(11):3747-50. doi: 10.1128/JCM.02037-12. Epub 2012 Aug 29. J Clin Microbiol. 2012. PMID: 22933593 Free PMC article.
-
In vitro activity of tigecycline against multidrug-resistant Enterobacteriaceae isolates from a Belgian hospital.Eur J Clin Microbiol Infect Dis. 2009 Apr;28(4):381-4. doi: 10.1007/s10096-008-0629-9. Epub 2008 Sep 19. Eur J Clin Microbiol Infect Dis. 2009. PMID: 18802728
References
-
- Babinchak, T., E. J. Ellis-Grosse, N. Dartois, G. M. Rose, and E. Loh. 2005. The efficacy and safety of tigecycline in the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. Clin. Infect. Dis. 41:S354-S367. - PubMed
-
- Bradford, P. A., P. J. Petersen, M. Young, C. H. Jones, M. Tischler, and J. O'Connell. 2005. Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent oxyrase to standardize the test method. Antimicrob. Agents Chemother. 49:3903-3909. - PMC - PubMed
-
- Bradford, P. A., D. T. Weaver-Sands, and P. J. Petersen. 2005. In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials for complicated skin and skin structure infections and complicated intra-abdominal infections. Clin. Infect. Dis. 41(Suppl. 5):S315-S332. - PubMed
-
- Brown, D. F., and L. Brown. 1991. Evaluation of the E test, a novel method of quantifying antimicrobial activity. J. Antimicrob. Chemother. 27:185-190. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases